Singapore legislation

Regulation 51

of Health Products (Therapeutic Products) Regulations 2016

Regulation 51

Import of therapeutic products for patients’ use without importer’s licence

Amended byS 811/2023 wef 18/12/2023S 436/2023 wef 26/06/2023S 811/2023 wef 18/12/2023

Subregulation 1

Amended byS 811/2023 wef 18/12/2023S 436/2023 wef 26/06/2023S 811/2023 wef 18/12/2023

Subject to paragraph (3), a specified healthcare service licensee may, without holding an importer’s licence, import a therapeutic product that is not registered, if the therapeutic product —

(a)

is required by, and on the written instructions of, a qualified practitioner who is a personnel of the specified healthcare service licensee; and

(b)

is for the use of the qualified practitioner’s patient.

Subregulation 2

Subject to paragraph (3), the holder of a pharmacy licence may import, without holding an importer’s licence, a therapeutic product that is not registered, if the therapeutic product is intended for the use by a patient of a qualified practitioner pursuant to a valid prescription given by the qualified practitioner.

Subregulation 3

The Authority’s prior approval must be obtained for each consignment of a therapeutic product that is imported under paragraph (1) or (2), and the amount imported must not exceed —

(a)

a total dosage of 3 months per patient as recommended by the manufacturer of the therapeutic product; or

(b)

such other quantity as approved by the Authority.

Subregulation 4

An application for the Authority’s approval under paragraph (3) must be made in the form and manner specified on the Authority’s website.